Platinum-Resistant Ovarian Cancer

CHESTERBROOK, Pa. — September 24, 2026 Persevere Therapeutics, Inc. announced that the first patient has been enrolled and treated...

REDWOOD CITY, Calif. — September 18, 2026 Corcept Therapeutics announced that the European Medicines Agency’s Committee for Medicinal Products...

LUND, Sweden, August 7, 2026 BioInvent International AB announced that the U.S. Food and Drug Administration (FDA) has granted...

San Diego, California, USA | July 17, 2026 Zentalis Pharmaceuticals announced that it will present new clinical data for...

SAN DIEGO, Calif., July 1, 2026 92Bio, Inc. announced that the first patient has been dosed in its Phase...

COPENHAGEN, Denmark, June 18, 2026 Allarity Therapeutics, Inc. announced the presentation of a Trial-in-Progress poster for its ongoing Phase...